Parth Rali

#Temple Lung center, #Pulm Critical Care #PE #Pulm Vascular disease# death from PE is not acceptable to me!

[Luis Jara-Palomares @luistrombo]

1/3 ¡Gracias @accpchest por invitarme como panelista español a #CHEST2026 en Phoenix, Arizona!

Un honor participar en “PE Pressure Cooker LIVE!” y debatir casos complejos de embolia pulmonar con un panel multidisciplinar en Estados Unidos.

[Francisco Soto, MD, MS, MBA @FSotoMD]

Friend: "I still struggle managing pulmonary hypertension if the disease doesn't follow the guidelines"

Me: "Aren't you going to CHEST 2026 in Phoenix?"

Friend: "Yes! Why?"

Me: "Say no more!"

The @accpchest and its @CHESTPulmCardio have assembled a session just for you:

"Guidelines vs Real-Life Expert Decisions in Pulmonary Hypertension Treatment: A Conversation With Experts"

🌵🌵🌵🌵

Six legendary PH authorities will ride into town to track down the "WANTED" PH cases that keep us up at night.

Dr. Rali and I will present them with six such case scenarios and will have them answer the tough questions.

Check the attached flier and join us Sunday, October 18, 1:30 PM, at the 📍 Phoenix Convention Center, North Building, Room 226 A

Ride in early and claim your seat. Or you may be left outside eating Arizona dust!

#CHEST2026
#pulmonaryhypertension

@ParthRali
#OksanaShlobin
#JessicaHuston
@melendres_lana
@SandeepSahayMD
@AnnaHemnes
@hilarydubrockMD

@PVRI
@PHAssociation
@ATS_PC

[Healio Pulmonology @HealioPulm]

💬“These findings support further investigation of mosliciguat as a potentially important addition to the PH-ILD treatment landscape,” @ParthRali, MD, FCCP, @TempleHealth, told Healio.
https://t.co/Y8UdHYw8M9

[Francisco Soto, MD, MS, MBA @FSotoMD]

ACCP: “Pulmonary HTN runs wild in Phoenix. We are doomed!”

ACCP PVD Section: “Easy, partner. Our 6 top PH Marshals ride Sunday!”

Reminder to come see the PH Marshals in action:

"Guidelines vs Real-Life Expert Decisions in Pulmonary Hypertension Treatment: A Conversation With Experts"

🌵 🌵 🌵 🌵

WHEN: Sunday, October 18, at 1:30 PM
LOCATION:📍 Phoenix Convention Center, North Building, Room 226 A

Arrive early to secure your seat!

🌵 🌵 🌵 🌵

#CHEST2026

Link 👇🏻
https://t.co/Mzm6Y9d35C

@ParthRali
#OksanaShlobin
#JessicaHuston
@melendres_lana
@SandeepSahayMD
@AnnaHemnes
@hilarydubrockMD

@accpchest
@CHESTPulmCardio
@PVRI
@PHAssociation
@ATS_PC

[Healio Pulmonology @HealioPulm]

💬“This analysis offers reassurance that the safety profile [of #Winrevair] remains consistent in broader patient populations and highlights how clinicians are adapting novel therapies to address unmet needs,” Dr. @ParthRali, @TempleHealth, said. #PAH
https://t.co/TgcYnqcGsV

[Parth Rali @ParthRali]

@Temple_LKSOM @TempleLung @TempleMedNews @TempleHealth @TempleIM !!!

[Francisco Soto, MD, MS, MBA @FSotoMD]

ACCP: “Pulmonary HTN runs wild in Phoenix. We are doomed!”

ACCP PVD Section: “Easy, partner. Our 6 top PH Marshals ride Sunday!”

Reminder to come see the PH Marshals in action:

"Guidelines vs Real-Life Expert Decisions in Pulmonary Hypertension Treatment: A Conversation With Experts"

🌵 🌵 🌵 🌵

WHEN: Sunday, October 18, at 1:30 PM
LOCATION:📍 Phoenix Convention Center, North Building, Room 226 A

Arrive early to secure your seat!

🌵 🌵 🌵 🌵

#CHEST2026

Link 👇🏻
https://t.co/Mzm6Y9d35C

@ParthRali
#OksanaShlobin
#JessicaHuston
@melendres_lana
@SandeepSahayMD
@AnnaHemnes
@hilarydubrockMD

@accpchest
@CHESTPulmCardio
@PVRI
@PHAssociation
@ATS_PC

[Temple Health @TempleHealth]

AI is changing pulmonary care at #TempleHealth, supporting earlier detection and more informed treatment decisions.

Dr. @ParthRali, Dr. Cohen & Dr. Criner share how in the latest Temple Lung Center Winter Magazine: https://t.co/bMRMHENAcG @katztemplemed

[Parth Rali @ParthRali]

It is happening tomorrow ! Last chance

[Francisco Soto, MD, MS, MBA @FSotoMD]

Colleague: “Pulmonary vascular disease is changing too fast. I can’t keep up anymore.😞😞
Wish there was a meeting in the NY area for me to catch up...”

Me: “Wait! Did you just say, New York?”

Colleague: “Yes. Why?”

Me: “Say no more. You’re in luck! ✅✅

Next Saturday, April 18, the PVD symposium by @NorthwellHealth and @TempleHealth brings together key PVD experts to share updates. I'll be helping with two talks."

You'll learn about:

🔹 PE risk stratification
🔹 Echocardiography in PE
🔹 The 2026 multi-society PE guidelines
🔹 PE treatment (invasive and non-invasive)
🔹 Post PE syndrome
🔹 PH and PAH classification
🔹 PAH risk stratification and treatment
🔹 Imaging in PH
🔹 Group 2 PH (including sotatercept/CADENCE insights)
🔹 And more!

Colleague: “Wow. This thread somehow sounds like a cheap infomercial, but I’m in. Where do I sign up?”

Me: “Check the link below👇to sign up and see the brochure.
And yes. I am counting on your applause.” 😏

https://t.co/O8CA3bIpSo

🔥Great activity for:
🔸Physicians
🔸Fellows/Residents
🔸Medical students (Free!!)
🔸Nurse practitioners
🔸Physician Assistants
🔸Nurses
🔸Other health care team members interested in PVD

Course directors:
@ParthRali
@mina_bushra
@chadkligermd
@ScheinerMD
#medtwitter
*No virtual attendance or recorded sessions options

[Francisco Soto, MD, MS, MBA @FSotoMD]

Colleague: “Pulmonary vascular disease is changing too fast. I can’t keep up anymore.😞😞
Wish there was a meeting in the NY area for me to catch up...”

Me: “Wait! Did you just say, New York?”

Colleague: “Yes. Why?”

Me: “Say no more. You’re in luck! ✅✅

Next Saturday, April 18, the PVD symposium by @NorthwellHealth and @TempleHealth brings together key PVD experts to share updates. I'll be helping with two talks."

You'll learn about:

🔹 PE risk stratification
🔹 Echocardiography in PE
🔹 The 2026 multi-society PE guidelines
🔹 PE treatment (invasive and non-invasive)
🔹 Post PE syndrome
🔹 PH and PAH classification
🔹 PAH risk stratification and treatment
🔹 Imaging in PH
🔹 Group 2 PH (including sotatercept/CADENCE insights)
🔹 And more!

Colleague: “Wow. This thread somehow sounds like a cheap infomercial, but I’m in. Where do I sign up?”

Me: “Check the link below👇to sign up and see the brochure.
And yes. I am counting on your applause.” 😏

https://t.co/O8CA3bIpSo

🔥Great activity for:
🔸Physicians
🔸Fellows/Residents
🔸Medical students (Free!!)
🔸Nurse practitioners
🔸Physician Assistants
🔸Nurses
🔸Other health care team members interested in PVD

Course directors:
@ParthRali
@mina_bushra
@chadkligermd
@ScheinerMD
#medtwitter
*No virtual attendance or recorded sessions options

[Parth Rali @ParthRali]

@GayenShameek @TemplePCCM @MarioNaranjoMD @CHESTPulmCardio Excellent work!! More to come, @GayenShameek no breaks for you!! Keep it up

[Shameek Gayen @GayenShameek]

Quantitative CT analysis can accurately phenotype and prognosticate survival in #COPD #pulmonaryhypertension! See our work led by @TemplePCCM fellow Ahmad Raza in CHEST Pulmonary https://t.co/E2HrWb1nkk @ParthRali @MarioNaranjoMD @CHESTPulmCardio

[Temple Lung Center @TempleLung]

The latest Temple Lung Center Magazine highlights new approaches to treating Pulmonary Embolism.

In this article, @ParthRali & Dr. Patel share how the Temple Lung Center’s Pulmonary Embolism Response Team (PERT) is advancing rapid-response PE care: https://t.co/9AIzajFGBz

[F Mae West, MD MS @FMaeWestMD]

Calling all trainees and future VTE leaders!! 1 week left to apply for The @PERTConsortium Trainee Council!

[Temple Lung Center @TempleLung]

Temple Health was proud to join colleagues at @NorthwellHealth's recent #COPD Symposium, advancing education and collaboration in COPD and advanced lung disease. @ParthRali

[Parth Rali @ParthRali]

@TemplePCCM ! Please apply and join

[The PERT Consortium® @PERTConsortium]

The PERT Consortium® is calling all researchers, authors, and investigators to submit their pulmonary embolism research proposals. Accepted proposals will be pursued by the PERT Research Committee, in collaboration with the submitting researcher. Proposals may seek to leverage the real-world-evidence housed in The PERC® Database.

Research proposals may be submitted here:
https://t.co/6eOnPj3DVV

The deadline for submission is November 30, 2025.
#PE #PERT

[Temple Health @TempleHealth]

Global collaboration is shaping the future of pulmonary vascular care.

The Temple Lung Center is partnering with global leaders in pulmonary vascular research to advance best practices, accelerate innovation, and improve patient outcomes worldwide.

[Parth Rali @ParthRali]

@LaurentBertole1 Fantastic work

[Temple Lung Center @TempleLung]

The Temple Lung Center is at #CHEST2025! Visit us at booth #612 to learn about our advanced clinical offerings.

[Parth Rali @ParthRali]

@ktfitt87 - thank you!

[Parth Rali @ParthRali]

@accpchest fellows course #CHEST2025, Teaching 170 pulmonary critical fellows in a day on various topics including Pulmonary HTN and PE, was amazing beginning for the conference!! Future is bright, Right ventricle is not forgotten anymore! @TemplePCCM @TempleIM @TempleHealth

[Parth Rali @ParthRali]

Wonderful colleagues from all over the country, and special thank you to Dr Talal Dahan and Katie Fitton for involving me!! I was so happy to see our second year rock star fellow suzanna tolento!!